Fact CheckerSign in

NCT07528937Not yet recruiting

Application of 3D Reconstruction for Preoperative Strategy of Locally Advanced Colon Cancer

Randomized Multicenter Study Protocol: Application of 3D Reconstruction for Preoperative Strategy of Locally Advanced Colon Cancer

Source: ClinicalTrials.gov · Last updated 21 Apr 2026

Brief summary (registry, in English)

The aim of this study is to assess the usefulness of a mathematical model of three-dimensional image process and reconstuction (3D-IPR) as a surgical planner in locally advanced colon cancer. In addition to comparing the diagnostic accuracy of this planner with that of the CT regarding the infiltration of neighbouring structures.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
168 (estimated)
First submitted
23 Mar 2026
Start date
1 May 2026
Primary completion date
1 May 2028
Lead sponsor
Fundació d'investigació Sanitària de les Illes Balears
NCT number
NCT07528937

What you commit to

  • Study type: Interventional
  • Planned participants: 168
  • From 1 May 2026 to the primary completion date, 1 May 2028
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with tumors with infiltration considered to be unresectable (pre-surgical or intraoperatively), since the anatomical-pathological analysis will not be available.

Other

  • Suspected carcinomatosis on preoperative CT or intraoperative finding
  • Suspected distant metastasis on preoperative CT or intraoperative finding

Who the study is looking for

  • Patients of both sexes, aged ≥18 years.
  • Adenocarcinoma of the right, left, sigmoid and recto-sigmoid junction that have cT3 or cT4a/b according to the eighth TNM edition of the American Joint Committee on Cancer (AJCC). Pre-treatment diagnosis by imaging (CT) test.
  • Lymph node extension: cN0, the presence of cN1/2 according to AJCC TNM 8th edition is allowed as long as they can be resected. Pretreatment diagnosis by imaging (CT) test.
  • Patients who access and sign informed consent for the surgical intervention.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.